Christopher Lines Selected Research

Christopher Lines Research Topics

Disease

23	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2023 - 02/2010
15	Migraine Disorders (Migraine) 02/2016 - 02/2006
9	Pain (Aches) 01/2013 - 12/2008
8	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 12/2011
5	Sleepiness 01/2020 - 01/2011
5	Headache (Headaches) 02/2016 - 02/2006
4	Nausea 11/2014 - 12/2008
3	Dementia (Dementias) 01/2023 - 01/2020
3	Parkinson Disease (Parkinson's Disease) 11/2017 - 12/2015
3	Major Depressive Disorder (Major Depressive Disorders) 01/2017 - 02/2006
2	Obstructive Sleep Apnea 01/2016 - 10/2013
2	Disorders of Excessive Somnolence (Hypersomnia) 12/2013 - 10/2013
2	Schizophrenia (Dementia Praecox) 05/2013 - 03/2013
2	Cognitive Dysfunction 05/2013 - 12/2011
2	Dizziness (Lightheadedness) 04/2011 - 01/2011
1	Dyskinesias (Dyskinesia) 11/2017
1	Apnea 01/2016
1	Constipation 12/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2015
1	Hypoxia (Hypoxemia) 03/2015
1	Vomiting 11/2014
1	Psychotic Disorders (Schizoaffective Disorder) 03/2013
1	Sleep Wake Disorders 02/2013
1	Anxiety Disorders (Anxiety Disorder) 02/2013
1	Ocular Hypertension (Glaucoma, Suspect) 06/2012
1	Pruritus (Itching) 06/2012
1	Hyperemia 06/2012
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 06/2012
1	Diarrhea 05/2012
1	Spasm (Spasms) 05/2012
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2012
1	Fatigue 04/2011
1	Tremor (Tremors) 04/2011
1	Epilepsy (Aura) 12/2010
1	Photophobia (Light Sensitivity) 12/2008
1	Hyperacusis (Phonophobia) 12/2008
1	Heart Failure 03/2005
1	Pulmonary Edema 03/2005
1	Adenoma (Adenomas) 03/2005
1	Polyps 03/2005
1	Myocardial Infarction 03/2005

Drug/Important Bio-Agent (IBA)

19	suvorexantIBA 01/2023 - 12/2012
17	Orexin Receptor AntagonistsIBA 12/2021 - 12/2012
10	telcagepantIBA 02/2016 - 12/2008
9	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 02/2016 - 12/2010
4	verubecestatIBA 01/2023 - 01/2019
4	Calcitonin Gene-Related PeptideIBA 09/2014 - 12/2008
3	MK-0249IBA 10/2013 - 05/2012
3	rizatriptan (Maxalt)FDA Link 01/2013 - 01/2011
3	Tryptamines (Triptans)IBA 02/2012 - 12/2008
3	zolmitriptan (Zomig)FDA Link 02/2011 - 12/2008
2	gaboxadol (THIP)IBA 01/2020 - 02/2010
2	Levodopa (L Dopa)FDA LinkGeneric 11/2017 - 12/2015
2	2- (2- furanyl)- 7- (2- (4- (4- (2- methoxyethoxy)phenyl)- 1- piperazinyl)ethyl)- 7H- pyrazolo(4,3- e)(1,2,4)triazolo(1,5- c)pyrimidine- 5- amineIBA 06/2017 - 12/2015
2	Adenosine (Adenocard)FDA LinkGeneric 06/2017 - 12/2015
2	Antidepressive Agents (Antidepressants)IBA 01/2017 - 11/2014
2	MK-6096IBA 01/2017 - 04/2015
2	Orexin ReceptorsIBA 04/2015 - 12/2012
2	Neurokinin-1 Receptor AntagonistsIBA 11/2014 - 02/2013
2	Aprepitant (Emend)FDA Link 11/2014 - 02/2006
2	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 09/2014 - 12/2008
2	Modafinil (Provigil)FDA Link 12/2013 - 10/2013
2	Histamine (Histamine Dihydrochloride)FDA Link 12/2013 - 05/2013
2	Histamine H3 Receptors (Histamine H3 Receptor)IBA 10/2013 - 12/2011
2	Ibuprofen (Motrin)FDA LinkGeneric 04/2011 - 02/2006
2	rofecoxib (Vioxx)FDA Link 02/2006 - 03/2005
1	lanabecestatIBA 11/2020
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 11/2020
1	Zolpidem (Ambien)FDA LinkGeneric 01/2018
1	N-Methylaspartate (NMDA)IBA 11/2017
1	4-methylbenzyl 3- fluoro- 4- ((pyrimidin- 2- ylamino)methyl)piperidine- 1- carboxylateIBA 11/2017
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2017
1	GoldIBA 03/2015
1	Hypnotics and Sedatives (Sedatives)IBA 03/2015
1	Paroxetine (Paxil)FDA LinkGeneric 11/2014
1	MK-7288IBA 12/2013
1	Antipsychotic Agents (Antipsychotics)IBA 05/2013
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 03/2013
1	Olanzapine (Zyprexa)FDA Link 03/2013
1	Lorazepam (Ativan)FDA LinkGeneric 02/2013
1	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 06/2012
1	Timolol (Blocadren)FDA LinkGeneric 06/2012
1	tafluprostIBA 06/2012
1	Scopolamine (Hyoscine)FDA Link 12/2011
1	Donepezil (Aricept)FDA LinkGeneric 12/2011
1	Cholinergic Agents (Cholinergics)IBA 12/2011
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 12/2011
1	2- (8- (3,5- difluorophenyl)- 10- oxo- 6,9- diazaspiro(4.5)dec- 9- yl)- N- (2'- oxo- 1,1',2',3- tetrahydrospiro(indene- 2,3'- pyrrolo(2,3- b)pyridin)- 5- yl)acetamideIBA 04/2011
1	Acetaminophen (Paracetamol)FDA LinkGeneric 04/2011
1	Vasoconstrictor AgentsIBA 12/2008
1	Substance PIBA 02/2006
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2005

Therapy/Procedure

3	Therapeutics 01/2017 - 10/2013
1	Wearable Electronic Devices 12/2021
1	Intravenous Infusions 11/2017
1	Drug Therapy (Chemotherapy) 11/2014
1	Continuous Positive Airway Pressure 10/2013
1	Aftercare (After-Treatment) 12/2008
1	Chemoprevention 03/2005